O’Melveny has advised Cantor Fitzgerald & Co.; DLA Piper has advised ACP Holdings Acquisition Corp.; Latham & Watkins has advised May Mobility. May Mobility, Inc., a...
May Mobility and ACP Holdings Announce $1.4 Billion Business Combination
Beren Therapeutics Secures $300 Million in Equity, Debt, and Royalty Financing
Wilson Sonsini Goodrich & Rosati has advised Beren Therapeutics P.B.C. Latham & Watkins has advised Hercules Capital, Inc. Beren Therapeutics P.B.C., a biotechnology company and parent...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Kandou AI Raises USD 225 Million in Strategic Investment Round
Niederer Kraft Frey has advised several investors. Latham & Watkins has advised Maverick Silicon. Homburger has acted for Kandou AI. Kandou AI has successfully completed a...
Paratek Pharmaceuticals Completes Combination with Radius Health and Secures $1.3 Billion Financing
Skadden has advised B-FLEXION Life Sciences and Paratek Pharmaceuticals. Mintz has advised Sixth Street. Latham & Watkins has advised Blackstone Credit & Insurance. Paratek Pharmaceuticals, Inc.,...
Viridian Therapeutics Royalty Financing Agreement with DRI Healthcare for up to $300 Million
Ropes & Gray has advised Viridian Therapeutics. Weil and Ballard Spahr have advised DRI Healthcare. Latham & Watkins has advised the lender, Hercules Capital, on the...
Wolfspeed Reduces Debt Through Comprehensive Financial Restructuring Agreement
Latham & Watkins has advised Wolfspeed, while Kirkland & Ellis and Haynes Boone have advised Renesas Electronics Corporation and its subsidiary. Wolfspeed, Inc. has completed a...
HealthCare Royalty and Blue Owl Capital Acquire BridgeBio Pharma’s BEYONTTRA Royalty Interest for $300 Million
Gibson Dunn has advised HealthCare Royalty and Blue Owl Capital, and Latham & Watkins has advised BridgeBio Pharma. HealthCare Royalty and Blue Owl Capital have acquired...
Carlyle and SK Capital’s Acquisition of bluebird bio
Wachtell, Lipton, Rosen & Katz, Kirkland & Ellis, and Orrick, Herrington & Sutcliffe are serving as legal advisors to Carlyle and SK Capital, while Latham &...
Verona Pharma’s $650 Million Financing Round
Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Seres Therapeutics’ VOWST Asset Purchase Agreement With Nestlé Health Science
Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
scPharmaceuticals’ $125 Million Senior Secured Term Loan
Latham & Watkins advised scPharmaceuticals on the deal. scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...